Table 1.
Demographic and clinical characteristics of 150 patients with Guillain‐Barré syndrome.
| Characteristic | n (%) |
|---|---|
| Age, mean (standard deviation) | 51.0 (16.1) |
| Male/female ratio | 1.2 (81/69) |
| Antecedent infection within 4 weeks | |
| Upper respiratory tract infection | 36 (24) |
| Gastrointestinal infection | 19 (13) |
| Motor deficits | |
| Upper and lower limb weakness | 111 (74) |
| Upper limb weakness only | 5 (3) |
| Lower limb weakness only | 11 (7) |
| None | 23 (15) |
| Sensory deficits | 62 (41) |
| Cranial nerve involvement | |
| Oculomotor weakness | 23 (15) |
| Facial weakness | 30 (20) |
| Bulbar weakness | 29 (19) |
| None | 68 (45) |
| Ataxia | 6 (4) |
| Tendon reflex at the nadir | |
| Hyporeflexia or areflexia | 128 (85) |
| Normal | 22 (15) |
| Pain | 13 (9) |
| Disability score at the nadir | |
| 1 | 35 (23) |
| 2 | 31 (21) |
| 3 | 20 (13) |
| 4 | 45 (30) |
| 5 | 17 (11) |
| 6 | 2 (1) |
| Albuminocytological dissociation in CSF | 95/123 (77) |
| Single nerve conduction study | |
| Primary demyelinating | 41/120 (34) |
| Primary axonal | 35/120 (29) |
| Unclassified | 27/120 (23) |
| Normal | 17/120 (14) |
| Disability score at 12 months | |
| 0–1 | 113/146 (77) |
| 2 | 13/146 (9) |
| 3 | 8/146 (6) |
| 4 | 5/146 (3) |
| 6 | 7/146 (5) |
| Pretreatment liver dysfunction | 13 (17/132) |
CSF, cerebrospinal fluid.